Navigation Links
Tracleer(R) Shows Clinical Benefit as Combination Therapy with Sildenafil for Pulmonary Arterial Hypertension
Date:10/23/2007

stage PAH patients as a monotherapy.

About Tracleer(R) in Pulmonary Arterial Hypertension (PAH)

Tracleer(R) (bosentan), the first oral dual endothelin receptor antagonist, is approved for the treatment of pulmonary arterial hypertension (PAH) and made available by Actelion Ltd. subsidiaries in the United States, the European Union, Japan, Australia, Canada, Switzerland and other markets worldwide.

Tracleer requires attention to two significant safety concerns: potential for serious liver injury (including rare cases of liver failure and unexplained hepatic cirrhosis in a setting of close monitoring) and high potential for major birth defects. Liver monitoring of all patients is essential prior to initiation of treatment and monthly thereafter. Pregnancy must be excluded and prevented by two forms of birth control; monthly pregnancy tests should be obtained. Because of these risks, Tracleer is only supplied through a controlled distribution system.

About Actelion Pharmaceuticals

Actelion Pharmaceuticals has pioneered research and development in the pulmonary arterial hypertension (PAH) disease area. More than 40,000 PAH patients have been prescribed Actelion's product Tracleer(R) (bosentan), an orally available dual endothelin receptor antagonist for patients with World Health Organization (WHO) Class III or IV PAH in the U.S., and Class III PAH in Europe. Tracleer was approved in 2001 as the first oral treatment for PAH, and is currently approved in the U.S., the European Union, and other markets worldwide. In January 2007, Actelion acquired CoTherix, Inc., whose product Ventavis(R) (iloprost) Inhalation Solution is approved and marketed in the United States for the treatment of patients with WHO Class III or IV PAH.


'/>"/>
SOURCE Actelion Pharmaceuticals US, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
2. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
3. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
4. MediGene Announces Cancer-Fighting Virus Shows Promise in Early Clinical Trial
5. Study Shows Ixabepilone Demonstrated Clear Activity in Patients with Metastatic Breast Cancer Resistant to Anthracycline, Taxane, and Capecitabine
6. Ceragenix Compound Shows Promise for Treating Lethal Cystic Fibrosis Infections
7. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
8. CombinatoRx Product Candidate CRx-150 Shows Activity on DAS28 and Pain, but Not CRP
9. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
10. First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes
11. New Poll Shows Men, Women Incorrectly Blame Symptoms of Low Testosterone on Normal Aging
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... THE WOODLANDS, Texas, Dec. 14 /PRNewswire/ ... investigators affiliated with US Oncology ... were presented orally at the ... , held Dec. 9-13 at the ... in San Antonio, Texas . ...
(Date:12/14/2009)... BEACH, Fla., Dec. 14 Perry Baromedical, ... years, announces the launch of the Sigma Elite, ... technology of the Sigma Elite is available on ... ) and has a Patent Pending. ,, The ... Data Capture Via Computerized System for Each ...
(Date:12/14/2009)... Sword Diagnostics, Inc. is pleased to ... has issued patent number 7,599,057 titled "Method ... Raman Scattering" to the company. The patent covers ... ,, "The issuance of this patent supports ... our continued development and commercialization," said Dave Dingott, ...
Breaking Medicine Technology:US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 2US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 3US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 4US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 5US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 6US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 7US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 8US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 9Perry Baromedical Announces New Cutting Edge Technology With Patient Data Capture Capability 2ReBuilder Medical Technologies Inc Announces New York Marketing Agreement 55421 1ReBuilder Medical Technologies Inc Announces New York Marketing Agreement 55421 2PR Professionals Making Good Use of Social Media With Help From Twitter Webinars Run by BurrellesLuce 55418 1PR Professionals Making Good Use of Social Media With Help From Twitter Webinars Run by BurrellesLuce 55418 2PR Professionals Making Good Use of Social Media With Help From Twitter Webinars Run by BurrellesLuce 55418 3Twenty Two Regional Construction Firms Recognized for Their Commitment to Worker Safety 55413 1Twenty Two Regional Construction Firms Recognized for Their Commitment to Worker Safety 55413 2
... FDA Requests Enhancements to Risk Mitigation Strategies Consistent with ... ... Inc. (Nasdaq:,CEPH) announced today receipt of a complete response letter ... Drug Application,(sNDA) for FENTORA(R) (fentanyl buccal tablet) [C-II] as a ...
... Md., Sept. 15 Theranostics Health (TH) ... Certificate of Registration from the,Federal Government. This, ... the,State of Maryland Department of Health & ... diagnostic laboratory testing in the,disciplines/specialties of Immunology/protein ...
Other Medicine Technology:Cephalon Receives Complete Response Letter Regarding Request for Expanded FENTORA Label for Non-Cancer Breakthrough Pain 2Cephalon Receives Complete Response Letter Regarding Request for Expanded FENTORA Label for Non-Cancer Breakthrough Pain 3Cephalon Receives Complete Response Letter Regarding Request for Expanded FENTORA Label for Non-Cancer Breakthrough Pain 4Theranostics Health Receives Green Light to Perform Clinical Testing 2
(Date:12/14/2009)... liposuction and fat transfer treatments can help people slim down, ... invasive treatment. , ... (PRWEB) December ... remove excess fat from the abdomen and inject it into ... facial wrinkling and enhance lips all in one safe, minimally ...
(Date:12/14/2009)... LOVELAND, Colo., Dec. 14 Heska ... the "Company"), a leading provider of veterinary ... first customer installation of the Company,s new ... 7000"). ,, (Logo: http://www.newscom.com/cgi-bin/prnh/20000622/HESKALOGO ) ,, ... the fastest multi-patient clinical chemistry analyzer available ...
(Date:12/14/2009)... -- United Dental Care (also known as Culver ... top-notch dental care in Southern California. We provide treatments ... braces (orthodontics) and periodontal treatments. Beverly Hills Dentist ... are staffed with experienced and trusted dentists who provide ... (Dr. E) is one of these trusted dentists. He ...
(Date:12/14/2009)... years under government controlled health care, before moving to the U.S. ... and in his new book, Health Reform: The End of the ... system and its threat to real health care! , ... ... diagnostic radiologist from Minnesota, warns Americans not to sell out their ...
(Date:12/14/2009)... NEW YORK, Dec. 14 /PRNewswire-USNewswire/ -- The ... the largest survey on teen drug abuse tracking over ... teens, intentional abuse of prescription (Rx) and over-the-counter (OTC) ... an alarming number of young people abusing medicines they ... Teen Abuse of Medication Continues to Be a Pervasive ...
Breaking Medicine News(10 mins):Health News: Free Webinar Series at Aqualipo.com Shows How New Combination Liposuction/Fat Transfer Treatment Helps Patients Slim Down and Reduce Facial Wrinkling 2Health News: Free Webinar Series at Aqualipo.com Shows How New Combination Liposuction/Fat Transfer Treatment Helps Patients Slim Down and Reduce Facial Wrinkling 3Health News:Heska Announces Installation of New Chemistry Analyzer 2Health News:Heska Announces Installation of New Chemistry Analyzer 3Health News:United Dental Care, Gentle Care, Trusted Dentists 2Health News:United Dental Care, Gentle Care, Trusted Dentists 3Health News:Canadian Doctor Warns Against Government-Run, Socialized Medicine and its Threat to Health Care and Freedom in America 2Health News:Partnership for a Drug-Free America(R) Responds to 2009 Monitoring the Future Study Results 2Health News:Partnership for a Drug-Free America(R) Responds to 2009 Monitoring the Future Study Results 3
... breakthrough in the treatment of coronary artery disease promises ... Medical research has come up with a drug-coated stent ... shown an ability to check the recurrence of blockages, ... results of this new procedure, based on a scientific ...
... disease Systemic Lupus Erythematosis has been solved by the ... the University of California, San Diego School of Medicine ... report in a nationa journal say that a gene ... symptoms remarkably similar to human SLE.// ,SLE is ...
... device to detect cervical cancer,has been developed by Australians which ... in the UK, Italy, Spain as well as Australia. ... collaboration with CSIRO and claims that it offers instant results ... a pen-like probe to collect information directly from the cervix ...
... Scientists working on the 10-year international Human Genome Project ... the highest concentration of disease genes.Out of 23 pairs ... with genetic disease. , Over the next 20 years ... Cambridge, eastern England will have a large impact on ...
... thing in medical research from the field of orthopedics is the use of ... to be true but read on to know more. , ... broken, and you have a cast and you are asked to wait for ... Imagine the amount of trauma and agony you would go through!// ...
... States of America, have transplanted a bovine jugular vein to a ... weakened valve of a vein in his right leg. This is ... treat varicose ulcers. , ... are ecstatic that the procedure has succeeded very well. Dr. Hugh ...
Other Medicine News:Health News:Bypassing open heart bypass surgery... 2Health News:Identification of gene 2Health News:Scientists use plastic to help body make new bone!!!! 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: